Copley Scientific has announced that it will introduce the new Child Alberta Idealised Throat for inhaler testing at Drug Delivery to the Lungs 24 along with its recently introduced TPK-R critical flow controller. The child version of the Alberta Idealised Throat (AIT) is designed to provide cascade impactor data with greater in vivo relevance for pediatric … [Read more...] about Copley to introduce Child Alberta Idealised Throat at DDL
News
Japanese launches for Flutiform, Ultibro
Two inhalation combination products have been launched in Japan within a day of each other. Skyepharma has announced that its Japanese partner Kyorin launched a 56-inhalation version of the Flutiform fluticasone/formoterol MDI, and Sosei has announced that Novartis Pharma KK launched Ultibro glycopyrronium/indacaterol inhalation capsules for the treatment of COPD. … [Read more...] about Japanese launches for Flutiform, Ultibro
Cornerstone launches Bethkis tobramycin inhalation solution
Cornerstone Therapeutics has launched Bethkis tobramycin inhalation solution for the treatment of cystic fibrosis patients with P. aeruginosa infections in the US, the company said. According to Cornerstone, one dose of Bethkis contains 300 mg of tobramycin in 4 mls of solution and can be delivered in about 15 minutes using a PARI LC Plus nebulizer. The company … [Read more...] about Cornerstone launches Bethkis tobramycin inhalation solution
Inhalation Asia 2013 presentations now available online
In accordance with their promise to provide open access to meeting materials, the organizers of Inhalation Asia 2013 have made all of the presentations from the meeting available on the meeting's website. The presentations include research that is applicable globally as well as papers specific to Asia such as "Inhalation delivery of traditional Chinese medicine … [Read more...] about Inhalation Asia 2013 presentations now available online
Aradigm appoints Juergen Froehlich new chief medical officer
Aradigm has announced the appointment of Juergen Froehlich as Chief Medical Officer. Froehlich is formerly Head of Regulatory Affairs at Vertex Pharmaceuticals where he was responsible for regulatory submissions for Kalydeco. Both of Aradigm's inhaled ciprofloxacin formulations, Pulmaquin and Lipoquin, were licensed by Grifols earlier this year. Aradigm … [Read more...] about Aradigm appoints Juergen Froehlich new chief medical officer
Particle Sciences to develop intranasal progesterone for BHR Pharma
Particle Sciences has announced that it has been awarded a contract for development of an intranasal progesterone formulation for the treatment of traumatic brain injury by BHR Pharma, a subsidiary of Besins Healthcare. Besins announced in April 2013 that it had licensed the Muco (μco) intranasal system from Shin Nippon Biomedical Laboratories (SNBL) for nasal … [Read more...] about Particle Sciences to develop intranasal progesterone for BHR Pharma
Timer Designs launches Advair/Seretide Compliance Cradle
Dutch pharmaceutical compliance specialist Timer Designs has announced the launch of the Compliance Cradle for Advair/Seretide Diskus inhalers. The device monitors the presence of the Diskus and alerts patients to take a dose of the medication if the inhaler remains situated in the cradle past the scheduled dosing time. The Compliance Cradle utilizes an optical … [Read more...] about Timer Designs launches Advair/Seretide Compliance Cradle
Relvar Ellipta approved in EU
GSK and Theravance have announced that the European Commission has approved Relvar Ellipta fluticasone furoate/vilanterol (FF/VI) DPI for the treatment of asthma for patients whose disease is not adequately controlled by ICS plus an as-needed SABA and for COPD where patients do not have adequate control with regular bronchodilator use. Relvar has been approved in … [Read more...] about Relvar Ellipta approved in EU
Intertek announces new comprehensive OINDP services
Intertek, which recently acquired Melbourn Scientific, has announced the launch of development, formulation and characterization service for both large and small molecule inhaled and nasal drug products. The acquisition of Melbourn Scientific was announced in July 2013. The company's OINDP services include formulation, analytical method development and validation, … [Read more...] about Intertek announces new comprehensive OINDP services
Civitas gets new patent for inhaled L-dopa
The United States Patent and Trademark Office (USPTO) has issued Civitas Therapeutics US Patent No. 8,545,878, with an expiration date of November 16, 2032, for a patent titled “Capsules containing high doses of levodopa for pulmonary use.” Civitas says that it now has more than 115 patents related to its CVT-301 inhaled L-dopa for the treatment of Parkinson's … [Read more...] about Civitas gets new patent for inhaled L-dopa